Human dosimetry of free (211)At and meta-[(211)At]astatobenzylguanidine ((211)At-MABG) estimated using preclinical biodistribution from normal mice

BACKGROUND: (211)At is one of the ideal nuclides for targeted radionuclide therapies (TRTs). Meta-[(211)At]astatobenzylguanidine ((211)At-MABG) has been proposed for the treatment of pheochromocytoma. To effectively use these radiopharmaceuticals, dosimetry must be performed. It is important to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukon, Naoyuki, Zhao, Songji, Washiyama, Kohshin, Oriuchi, Noboru, Tan, Chengbo, Shimoyama, Saki, Aoki, Miho, Kubo, Hitoshi, Takahashi, Kazuhiro, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509022/
https://www.ncbi.nlm.nih.gov/pubmed/32960387
http://dx.doi.org/10.1186/s40658-020-00326-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509022/
https://www.ncbi.nlm.nih.gov/pubmed/32960387
http://dx.doi.org/10.1186/s40658-020-00326-7

Ejemplares similares